{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T21:08:49Z","timestamp":1775855329337,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jpainsymman.2025.10.014","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T16:25:34Z","timestamp":1761668734000},"page":"271-279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Subcutaneous Dexmedetomidine for Refractory Symptoms in a Hospice Inpatient Unit"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9603-3977","authenticated-orcid":false,"given":"Holly","family":"Tate","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3822-3595","authenticated-orcid":false,"given":"Lana","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jpainsymman.2025.10.014_bib0001","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s40265-015-0419-5","article-title":"Dexmedetomidine: a review of its use for sedation in the intensive care setting","volume":"75","author":"Keating","year":"2015","journal-title":"Drugs"},{"issue":"1\u20132","key":"10.1016\/j.jpainsymman.2025.10.014_bib0002","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/15360288.2019.1629520","article-title":"Dexmedetomidine use in a case of severe cancer pain","volume":"33","author":"Seymore","year":"2019","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"11","key":"10.1016\/j.jpainsymman.2025.10.014_bib0003","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1089\/jpm.2019.0427","article-title":"Dexmedetomidine: a novel strategy for patients with intractable pain, opioid-induced hyperalgesia, or delirium at the end of life","volume":"23","author":"Hofherr","year":"2020","journal-title":"J Palliat Med"},{"issue":"11","key":"10.1016\/j.jpainsymman.2025.10.014_bib0004","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1089\/jpm.2019.0035","article-title":"Dexmedetomidine as an option for opioid refractory pain in the hospice setting","volume":"22","author":"Mupamombe","year":"2019","journal-title":"J Palliat Med"},{"issue":"3","key":"10.1016\/j.jpainsymman.2025.10.014_bib0005","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1177\/0269216314556923","article-title":"A case report of dexmedetomidine used to treat intractable pain and delirium in a tertiary palliative care unit","volume":"29","author":"Hilliard","year":"2015","journal-title":"Palliat Med"},{"issue":"9","key":"10.1016\/j.jpainsymman.2025.10.014_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0292016","article-title":"Dexmedetomidine use for patients in palliative care with intractable pain and delirium: a retrospective study","volume":"18","author":"Yu","year":"2023","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.jpainsymman.2025.10.014_bib0007","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1177\/0269216321994440","article-title":"Dexmedetomidine for hyperactive delirium at the end of life: an open-label single arm pilot study with dose escalation in adult patients admitted to an inpatient palliative care unit","volume":"35","author":"Thomas","year":"2021","journal-title":"Palliat Med"},{"issue":"1","key":"10.1016\/j.jpainsymman.2025.10.014_bib0008","doi-asserted-by":"crossref","first-page":"57","DOI":"10.21037\/apm-24-132","article-title":"Subcutaneous dexmedetomidine for sedation of agitated delirium in palliative care","volume":"14","author":"Lapenskie","year":"2025","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.jpainsymman.2025.10.014_bib0009","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2147\/CMAR.S404934","article-title":"Effect of dexmedetomidine for palliative sedation for refractory dyspnoea in patients with terminal-stage cancer","volume":"15","author":"Li","year":"2023","journal-title":"Cancer Manag Res"},{"issue":"8","key":"10.1016\/j.jpainsymman.2025.10.014_bib0010","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s40262-017-0507-7","article-title":"Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine","volume":"56","author":"Weerink","year":"2017","journal-title":"Clin Pharmacokinet."},{"issue":"4","key":"10.1016\/j.jpainsymman.2025.10.014_bib0011","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.21037\/apm-21-1989","article-title":"Dexmedetomidine: a magic bullet on its way into palliative care\u2014a narrative review and practice recommendations","volume":"11","author":"Gaertner","year":"2022","journal-title":"Ann Palliat Med"},{"issue":"10","key":"10.1016\/j.jpainsymman.2025.10.014_bib0012","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1089\/jpm.2023.0609","article-title":"Dexmedetomidine in palliative care: a versatile new weapon against delirium and pain\u2014systematic review","volume":"27","author":"Tavares","year":"2024","journal-title":"J Palliat Med"},{"issue":"3","key":"10.1016\/j.jpainsymman.2025.10.014_bib0013","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/anae.14472","article-title":"The effect of dexmedetomidine on delirium and agitation in patients in intensive care: systematic review and meta-analysis with trial sequential analysis","volume":"74","author":"Ng","year":"2019","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jpainsymman.2025.10.014_bib0014","doi-asserted-by":"crossref","first-page":"7507","DOI":"10.2147\/JIR.S346089","article-title":"Recent advances in the clinical value and potential of dexmedetomidine","volume":"14","author":"Liu","year":"2021","journal-title":"J Inflamm Res"},{"issue":"2","key":"10.1016\/j.jpainsymman.2025.10.014_bib0015","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s40122-023-00485-2","article-title":"Emergency palliative cancer care: dexmedetomidine treatment experiences\u2014a retrospective brief report on nine consecutive cases","volume":"12","author":"L\u00f8hre","year":"2023","journal-title":"Pain Ther"},{"issue":"7","key":"10.1016\/j.jpainsymman.2025.10.014_bib0016","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1253\/circj.CJ-19-0125","article-title":"Survey of palliative sedation at end of life in terminally ill heart failure patients - a single-center experience of 5-year follow-up","volume":"83","author":"Hamatani","year":"2019","journal-title":"Circ J"},{"issue":"e3","key":"10.1016\/j.jpainsymman.2025.10.014_bib0017","doi-asserted-by":"crossref","first-page":"e898","DOI":"10.1136\/spcare-2023-004252","article-title":"Dexmedetomidine for end of life sedation: retrospective cohort comparison study","volume":"13","author":"Thomas","year":"2023","journal-title":"BMJ Support Palliat Care"},{"issue":"1","key":"10.1016\/j.jpainsymman.2025.10.014_bib0018","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1472-684X-13-17","article-title":"The Richmond Agitation-Sedation Scale modified for palliative care inpatients (RASS-PAL): a pilot study exploring validity and feasibility in clinical practice","volume":"13","author":"Bush","year":"2014","journal-title":"BMC Palliat Care"},{"key":"10.1016\/j.jpainsymman.2025.10.014_bib0019","doi-asserted-by":"crossref","DOI":"10.2196\/55129","article-title":"Dexmedetomidine versus midazolam for end-of-life sedation and agitation: protocol for a randomized controlled trial (The DREAMS Trial)","volume":"13","author":"Thomas","year":"2024","journal-title":"JMIR Res Protoc"},{"issue":"5","key":"10.1016\/j.jpainsymman.2025.10.014_bib0020","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1080\/09699260.2021.1919045","article-title":"Does the addition of dexmedetomidine to morphine have any clinical benefit on the treatment of pain in patients with metastatic cancer? A pilot study","volume":"29","author":"Yamout","year":"2021","journal-title":"Prog Palliat Care"},{"issue":"1","key":"10.1016\/j.jpainsymman.2025.10.014_bib0021","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4321\/S1134-80462015000100002","article-title":"Comparaci\u00f3n entre dexmedetomidina en infusi\u00f3n intravenosa vs. lidoca\u00edna en infusi\u00f3n intravenosa para el control de dolor refractario a tratamiento opioide en pacientes de cuidados paliativos","volume":"22","author":"Carrillo","year":"2015","journal-title":"Rev Soc Esp Dolor SED"},{"issue":"e1","key":"10.1016\/j.jpainsymman.2025.10.014_bib0022","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1136\/bmjspcare-2020-002705","article-title":"Dexmedetomidine withdrawal syndrome and opioid sensitivity","volume":"13","author":"Ferguson","year":"2023","journal-title":"BMJ Support Palliat Care"},{"issue":"1\u20132","key":"10.1016\/j.jpainsymman.2025.10.014_bib0023","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/15360288.2019.1651439","article-title":"Use of dexmedetomidine for postoperative pain management following spine fusion surgery in a highly opioid-tolerant patient","volume":"33","author":"Wu","year":"2019","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"8","key":"10.1016\/j.jpainsymman.2025.10.014_bib0024","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1177\/02692163211022184","article-title":"Intranasal dexmedetomidine: Procedural sedation in palliative care: a case report","volume":"35","author":"Ferguson","year":"2021","journal-title":"Palliat Med"},{"issue":"8","key":"10.1016\/j.jpainsymman.2025.10.014_bib0025","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/jama.2022.0799","article-title":"Effect of sublingual dexmedetomidine vs placebo on acute agitation associated with bipolar disorder: a randomized clinical trial","volume":"327","author":"Preskorn","year":"2022","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.jpainsymman.2025.10.014_bib0026","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s40262-020-00900-3","article-title":"Population modelling of dexmedetomidine pharmacokinetics and haemodynamic effects after intravenous and subcutaneous administration","volume":"59","author":"Ashraf","year":"2020","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jpainsymman.2025.10.014_bib0027","unstructured":"Medsafe. Dexmedetomidine Accord concentrate for infusion data sheet. 2022. Available from: https:\/\/www.medsafe.govt.nz\/profs\/datasheet\/d\/dexmedetomidineAccordinj.pdf. Accessed March 25, 2025"},{"key":"10.1016\/j.jpainsymman.2025.10.014_bib0028","unstructured":"Ausvet. Epitools paired t-test or Wilcoxon signed rank test on numeric data. 2018. Available from: https:\/\/epitools.ausvet.com.au\/paired. Accessed April 22, 2025."},{"issue":"7","key":"10.1016\/j.jpainsymman.2025.10.014_bib0029","first-page":"587","article-title":"Applications of dexmdetomidine in palliative and hospice care","volume":"27","author":"Lemus","year":"2022","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.jpainsymman.2025.10.014_bib0030","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s00228-018-2461-1","article-title":"Subcutaneously administered dexmedetomidine is efficiently absorbed and is associated with attenuated cardiovascular effects in healthy volunteers","volume":"74","author":"Uusalo","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.jpainsymman.2025.10.014_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0294292","article-title":"A comparation of dexmedetomidine and midazolam for sedation in patients with mechanical ventilation in ICU: a systematic review and meta-analysis","volume":"18","author":"Wen","year":"2023","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.jpainsymman.2025.10.014_bib0032","first-page":"107","article-title":"Factors associated with the occurrence of adverse effects resulting from hypodermoclysis in older adults in palliative care: a cohort study","volume":"46","author":"de Souza","year":"2023","journal-title":"J Infus Nurs Off Publ Infus Nurses Soc"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392425009030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392425009030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T12:39:09Z","timestamp":1767011949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392425009030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0885392425009030"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2025.10.014","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subcutaneous Dexmedetomidine for Refractory Symptoms in a Hospice Inpatient Unit","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2025.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}